Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns76
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma69
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?67
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype48
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD44
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease40
HBV Biomarkers and Their Role in Guiding Treatment Decisions33
Genetic and Epigenetic Basis of Drug-Induced Liver Injury32
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease31
Hepatic Alveolar Echinococcosis28
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy28
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis24
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis24
Wilson Disease: Novel Diagnostic and Therapeutic Approaches23
Role of YAP1 Signaling in Biliary Development, Repair, and Disease22
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems21
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury21
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies20
Physiomimetic In Vitro Human Models for Viral Infection in the Liver19
Mice Engrafted with Human Liver Cells19
0.022178888320923